ISO 22716:2007 - Cosmetics GMP Lead Auditor Free Practice Test — 30 Questions

Question 1

During an audit of a cosmetic manufacturing facility, a lead auditor discovers that a specific batch of liquid foundation exhibited significant color variation, leading to its quarantine. The manufacturer has documented the quarantine and initiated a review of the production records for that batch. What is the most critical action for the lead auditor to verify to ensure the company\'s adherence to ISO 22716:2007 regarding non-conforming products and the effectiveness of their quality management system?

Accepted Answer

Review the documented corrective and preventive action (CAPA) plan initiated for the color variation, its implementation status, and evidence of its effectiveness in preventing recurrence.

Question 2

During an audit of a cosmetic manufacturing facility producing a new line of advanced facial serums, an auditor is reviewing the incoming raw material control process. A critical ingredient, vital for the serum\'s efficacy and stability, has been received. The manufacturer\'s Quality Control team has documented a visual inspection, confirming the raw material\'s appearance aligns with the approved specification. However, the auditor notes that no further analytical testing or supplier documentation verification beyond visual confirmation has been recorded for this batch. What is the most appropriate next step for the auditor to ensure compliance with ISO 22716:2007 regarding raw material control?

Accepted Answer

Request evidence of the supplier's Certificate of Analysis (CoA) or the manufacturer's internal testing results that confirm the raw material meets all specified chemical and physical parameters.

Question 3

During an audit of a cosmetic manufacturing facility, a lead auditor discovers that a specific packaging integrity issue, previously identified and documented as a non-conformity during the previous audit cycle, has recurred in multiple product batches produced since then. What is the most critical action the lead auditor should take to address this situation in accordance with ISO 22716:2007 principles?

Accepted Answer

Thoroughly investigate the effectiveness and adequacy of the manufacturer's corrective and preventive action (CAPA) system for addressing the identified packaging integrity issue.

Question 4

During an audit of a cosmetic manufacturing facility, a lead auditor observes that incoming batches of a key botanical extract are being stored in an open area adjacent to the packaging material staging zone, with no clear segregation or identification indicating their inspection status. The facility\'s quality control records show that the supplier\'s Certificate of Analysis (CoA) for the latest batch is still pending review by the QC department. What is the most significant GMP non-conformity identified in this scenario concerning ISO 22716:2007?

Accepted Answer

Inadequate control and segregation of incoming raw materials awaiting quality control approval.

Question 5

During an audit of a cosmetic manufacturing facility, a lead auditor discovers that a critical batch of facial serum was released for sale despite failing a key stability test due to an unvalidated equipment cleaning protocol. The manufacturer\'s internal documentation indicates that the deviation was noted, but the corrective action only involved re-testing the remaining samples from the same batch, which subsequently passed. What is the most appropriate auditor conclusion regarding the effectiveness of the manufacturer\'s deviation management system in this scenario?

Accepted Answer

The deviation management system is likely ineffective as it failed to address the root cause of the cleaning protocol issue and did not validate the corrective action's impact on future production.

Question 6

During an audit of a cosmetic manufacturing facility, a lead auditor is reviewing the personnel training program. The facility has documented training sessions on general hygiene and specific production line operations. However, there is a noticeable increase in minor deviations related to material handling and packaging integrity in the past quarter. What is the most critical aspect for the lead auditor to investigate to determine the effectiveness of the personnel training program in relation to ISO 22716:2007 requirements?

Accepted Answer

The documented training program's alignment with current GMP principles and the specific job functions, coupled with evidence of its impact on employee performance and product quality.

Question 7

During an audit of a cosmetic manufacturing facility, an auditor is reviewing the procedures for raw material procurement. The company utilizes a wide range of ingredients, from simple emollients to complex botanical extracts and synthesized active compounds. The auditor needs to assess the effectiveness of the company\'s supplier qualification process in mitigating potential risks associated with these diverse materials. What specific aspect of the supplier qualification process should the auditor prioritize to ensure compliance with ISO 22716:2007 regarding raw material safety and quality?

Accepted Answer

Verifying that the supplier qualification process is directly informed by a risk assessment of the raw materials themselves, including their potential for contamination, degradation, or the presence of prohibited substances.

Question 8

During an audit of a cosmetic manufacturing facility, an auditor observes that a single ventilation system serves both the area where fragrance concentrates are handled and the area where sensitive, fragrance-free skincare emulsions are processed. The manufacturer acknowledges this as a potential risk for cross-contamination. They propose implementing enhanced HEPA filtration within the shared system and establishing rigorous, documented cleaning and air-purging protocols for the ventilation ducts between production runs of different product types. What is the most appropriate action for the lead auditor to take to ensure compliance with ISO 22716:2007 regarding this identified risk?

Accepted Answer

Verify the documented implementation and demonstrated effectiveness of the manufacturer's proposed enhanced filtration and cleaning protocols for the ventilation system.

Question 9

During an audit of a cosmetic manufacturing facility, an auditor is tasked with verifying compliance with the personnel requirements outlined in ISO 22716:2007. Which of the following actions represents the most fundamental and direct verification activity the auditor should undertake regarding the facility\'s personnel?

Accepted Answer

Reviewing training records and observing personnel hygiene practices in production areas.

Question 10

During an audit of a cosmetic manufacturing facility, a lead auditor discovers that a batch of raw material was used in production despite not fully meeting a minor, non-critical specification parameter due to a temporary equipment malfunction. The company\'s internal procedure for handling deviations requires investigation and documented justification for using out-of-specification materials. What is the primary focus of the lead auditor\'s verification in this scenario to ensure compliance with ISO 22716:2007?

Accepted Answer

The adequacy and execution of the company's documented deviation investigation, root cause analysis, and corrective/preventive action (CAPA) process for the specific instance.

Question 11

During an audit of a cosmetic manufacturing facility that outsources the synthesis of a key active ingredient, what is the primary focus for the lead auditor when evaluating the control of this outsourced process according to ISO 22716:2007?

Accepted Answer

Verification of the manufacturer's documented assurance that the outsourced process consistently yields results compliant with established specifications and regulatory mandates.

Question 12

During an audit of a cosmetic manufacturing facility, a lead auditor discovers that a crucial supplier of active botanical extracts, whose quality directly influences the efficacy and safety of several high-volume finished products, has never been subjected to the company\'s documented supplier qualification process. While the extracts themselves have met incoming quality control specifications for the past year, the absence of a formal evaluation of the supplier\'s own GMP compliance and quality systems is noted. What classification of non-conformity would be most appropriate for this finding according to ISO 22716:2007 principles?

Accepted Answer

Major non-conformity

Question 13

During an audit of a cosmetic manufacturing facility, a lead auditor discovers that a critical supplier of a unique botanical extract, whose quality directly impacts the final product\'s efficacy and safety, has not undergone a formal re-evaluation within the last 18 months, exceeding the company\'s stated 12-month internal policy for such suppliers. The supplier\'s performance records, however, show no significant quality deviations in the past year. What is the most appropriate course of action for the lead auditor to take to ensure compliance with ISO 22716:2007 principles?

Accepted Answer

Verify that the organization has implemented appropriate risk mitigation measures and corrective actions to address the potential impact of the lapsed re-evaluation on product quality and safety.

Question 14

A cosmetic manufacturer has contracted an external facility to perform terminal sterilization of its finished products. During an audit, it is discovered that the cosmetic manufacturer has not conducted any formal audits or assessments of the sterilization facility\'s quality management system or its sterilization process validation. The manufacturer relies solely on the sterilization facility\'s self-declaration of compliance with relevant standards. What is the most significant finding from a GMP auditing perspective concerning ISO 22716:2007?

Accepted Answer

Failure to adequately control outsourced sterilization processes through independent verification and documented agreements.

Question 15

A cosmetic manufacturer\'s internal audit reveals that a significant quantity of returned finished products, ostensibly due to minor packaging defects, were reintegrated into inventory and subsequently resold without a documented, comprehensive assessment of the product\'s internal quality and stability. As a lead auditor for ISO 22716:2007, what is the most critical corrective action to recommend to prevent recurrence and ensure compliance with Good Manufacturing Practices for cosmetic products?

Accepted Answer

Implement a mandatory quarantine and detailed quality assessment protocol for all returned finished products before any disposition, including verification of product integrity and stability.

Question 16

A lead auditor is reviewing the incoming goods inspection process at a cosmetic manufacturing facility. They discover that a recent delivery of a key preservative, essential for product stability and microbial control, arrived without the accompanying Certificate of Analysis (CoA) and the supplier\'s standard batch release documentation was also found to be incomplete. The supplier is a long-standing, approved vendor. What is the most appropriate immediate action for the facility to take to ensure compliance with ISO 22716:2007 and prevent potential product quality issues?

Accepted Answer

Quarantine the entire batch of the preservative pending verification of its conformity to specifications.

Question 17

During an audit of a cosmetic manufacturing facility, a significant product recall has been initiated due to the detection of an unexpected microbial contaminant in a specific batch of skincare cream. The recall was triggered by a customer complaint and subsequent internal investigation. As a lead auditor, what is the most critical piece of evidence to assess the effectiveness of the company\'s quality management system in managing this product safety issue, specifically concerning ISO 22716:2007 requirements for traceability and complaint handling?

Accepted Answer

Documented evidence of the complete recall process, including identification of affected batches, distribution records, and communication logs with affected parties.

Question 18

During an audit of a cosmetic manufacturing facility, an auditor discovers a batch of a key active ingredient that fails to meet the specified purity standards. Further investigation reveals that this ingredient is sourced from a single external supplier. What is the most critical action the lead auditor should prioritize to address this finding and ensure systemic compliance with ISO 22716:2007?

Accepted Answer

Assess the supplier's own quality management system and their adherence to relevant Good Manufacturing Practices for raw material production.

Question 19

During an audit of a cosmetic manufacturing facility that outsources its primary packaging printing to a third-party vendor, the auditor discovers that the vendor\'s quality control records are inconsistently maintained. The facility has a contract with the vendor that specifies quality requirements. What is the most crucial aspect for the lead auditor to verify regarding the facility\'s control over this external service provider to ensure compliance with ISO 22716:2007?

Accepted Answer

The existence and thoroughness of the facility's documented procedures for selecting, evaluating, and continuously monitoring the performance of external service providers, and evidence of their consistent application.

Question 20

During an audit of a cosmetic manufacturing facility, a lead auditor discovers that a new supplier of a critical botanical extract has been engaged, and this extract requires specific handling protocols due to its photosensitivity. The auditor needs to assess the facility\'s adherence to personnel competency requirements as outlined in ISO 22716:2007. What specific action should the auditor prioritize to confirm the facility\'s compliance in this scenario?

Accepted Answer

Reviewing documented evidence of training provided to personnel responsible for receiving, storing, and processing the new botanical extract, focusing on its specific handling requirements.

Question 21

During an audit of a cosmetic manufacturing facility, an auditor discovers that a batch of a critical raw material, essential for the product\'s preservative system efficacy, was received from an approved supplier without an accompanying Certificate of Analysis (CoA). The company\'s internal records indicate the material was subsequently released for production. What is the most appropriate action for the lead auditor to take to assess compliance with ISO 22716:2007?

Accepted Answer

Review the company's documented procedures for handling non-conforming raw materials and verify if the supplier was contacted to provide the missing CoA or if alternative verification methods were employed before release.

Question 22

During an audit of a cosmetic manufacturing facility, a lead auditor observes that a batch of \"Glow Serum Base,\" a critical raw material, was received without a documented visual inspection for container integrity or signs of contamination. Furthermore, this batch was subsequently stored in a general-purpose warehouse area, adjacent to packaging components for a different product line, rather than in the designated, climate-controlled zone for critical raw materials. What is the most accurate conclusion the lead auditor should draw regarding the company\'s adherence to ISO 22716:2007?

Accepted Answer

The company's procedures for raw material reception and storage are inadequate, presenting a risk to product integrity.

Question 23

During an audit of a cosmetic manufacturing facility, an auditor discovers a documented incident where a critical raw material batch was inadvertently contaminated with a different, non-cosmetic grade substance during transfer. The internal investigation report indicates the root cause was attributed to inadequate labeling of intermediate containers and a lack of visual verification by the operator. The company\'s Quality Assurance department has implemented a corrective action to retrain staff on labeling protocols and has added a secondary check step in the transfer procedure. As a lead auditor, what is the most critical aspect to verify regarding the company\'s response to this deviation to ensure compliance with ISO 22716:2007?

Accepted Answer

The thoroughness and effectiveness of the root cause analysis and the implemented corrective and preventive actions (CAPA) to prevent recurrence.

Question 24

During an audit of a cosmetic manufacturing facility, a lead auditor discovers that a significant portion of the product\'s primary packaging is handled by a third-party logistics provider. The manufacturer\'s internal documentation indicates a general awareness of this arrangement but lacks specific details on how the quality of the packaging process is monitored at the provider\'s site. What is the most critical action the lead auditor must take to verify compliance with ISO 22716:2007 in this scenario?

Accepted Answer

Scrutinize the contractual agreements and documented procedures for managing and monitoring the third-party logistics provider's operations related to packaging.

Question 25

During an audit of a cosmetic manufacturing facility adhering to ISO 22716:2007, an auditor observes a documented deviation where a batch of raw material was used without the required secondary quality control check due to a temporary lapse in personnel training verification. The facility\'s quality manager states that the operator responsible has been retrained and a note has been added to the batch record. What is the lead auditor\'s most critical next step in assessing compliance with the standard?

Accepted Answer

Evaluate the effectiveness of the retraining and the adequacy of the system update to prevent recurrence of the deviation.

Question 26

During an audit of a cosmetic manufacturing facility adhering to ISO 22716:2007, a lead auditor discovers that a significant portion of the primary packaging materials are sourced from a new, unverified supplier. The company\'s internal procedures for supplier qualification are documented but appear to have been bypassed for this particular vendor due to perceived urgency. What is the primary responsibility of the lead auditor in this situation concerning the integrity of the quality management system?

Accepted Answer

To verify that the company has a documented process for qualifying external service providers and assess whether this process was followed or if a documented deviation with risk assessment was implemented.

Question 27

During an audit of a cosmetic manufacturing facility, a lead auditor is reviewing the personnel training records. The auditor observes that while attendance sheets for various GMP training sessions are meticulously maintained, there is no clear evidence of how the effectiveness of this training has been assessed or how identified training gaps are addressed in subsequent programs. Considering the intent of ISO 22716:2007, what is the most critical aspect for the lead auditor to focus on to determine compliance with personnel qualification and training requirements?

Accepted Answer

The existence and implementation of a documented system for assessing training effectiveness and addressing identified competency gaps.

Question 28

During an audit of a cosmetic manufacturing facility, a lead auditor observes that while employees are generally clean and wear basic protective clothing, there is no documented system for assessing the ongoing competence of production staff in relation to specific GMP tasks, nor are there records of regular hygiene refresher training beyond initial onboarding. The facility\'s quality management system references general training but lacks specific modules on GMP compliance for each role and periodic competency evaluations. Which of the following findings would represent the most significant deviation from ISO 22716:2007 requirements concerning personnel?

Accepted Answer

Lack of a systematic, documented approach to assess and maintain personnel competence and hygiene beyond initial onboarding.

Question 29

During an audit of a cosmetic manufacturing plant, a lead auditor observes that while personnel wear clean lab coats, there is no specific provision for hairnets or masks in the primary production areas where sensitive liquid formulations are being filled. The facility\'s environmental monitoring program primarily focuses on microbial counts in water systems. What is the most critical deficiency from a GMP perspective, considering the potential for product contamination and the requirements of ISO 22716:2007?

Accepted Answer

Inadequate control of airborne particulate matter originating from personnel, posing a risk of physical contamination to the liquid formulations.

Question 30

During an audit of a cosmetic manufacturing facility, a lead auditor discovers that a specific deviation concerning the accurate labeling of batch numbers on finished products has been noted in three consecutive internal audits over the past year. The company\'s CAPA system has documented corrective actions for each instance, including retraining of personnel and a review of the labeling process. However, the deviation persists. What is the most critical action the lead auditor must take to ensure compliance with ISO 22716:2007 principles regarding continuous improvement and effective quality management?

Accepted Answer

Critically evaluate the thoroughness and accuracy of the root cause analysis for each documented instance of the labeling deviation and assess the effectiveness of the implemented preventive actions to preclude recurrence.

ISO 22716:2007 - Cosmetics GMP Lead Auditor Free Practice Test — 30 Questions

A lot more is already mapped out

About the ISO 22716:2007 - Cosmetics GMP Lead Auditor Certification